MONTRÉAL, Québec, Canada — September 15, 2026 — Glycovax Pharma today announced the appointment of Cédric Héroux as Chief Operating Officer (COO) and Thierry Cyr-Lafleur as Director of Business Development. The addition of these two executives will help Glycovax accelerate the execution, industrialization and commercialization of its technologies while strengthening its position within the Canadian and international life sciences ecosystem.
Posted in News